| 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis A Martínez–Yélamos, A Saiz, R Sanchez–Valle, V Casado, JM Ramon, ... Neurology 57 (4), 722-724, 2001 | 92 | 2001 |
| Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different S Abilleira, A Ribera, P Cardona, M Rubiera, E López-Cancio, S Amaro, ... Stroke 48 (2), 375-378, 2017 | 89 | 2017 |
| Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases J Bruna, S Martínez-Yélamos, A Martínez-Yélamos, F Rubio, T Arbizu Multiple Sclerosis Journal 12 (2), 169-173, 2006 | 69 | 2006 |
| Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability V Casado, S Martínez-Yélamos, A Martínez-Yélamos, O Carmona, ... BMC health services research 6, 1-8, 2006 | 67 | 2006 |
| Regression to the mean in multiple sclerosis S Martinez-Yelamos, A Martinez-Yelamos, GM Ozaeta, V Casado, ... Multiple Sclerosis Journal 12 (6), 826-829, 2006 | 57 | 2006 |
| Mechanical thrombectomy in and outside the REVASCAT trial: insights from a concurrent population-based stroke registry X Urra, S Abilleira, L Dorado, M Ribó, P Cardona, M Millán, A Chamorro, ... Stroke 46 (12), 3437-3442, 2015 | 54 | 2015 |
| Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: a study of 20 patients A Riera-Mestre, S Martínez-Yelamos, A Martínez-Yelamos, I Ferrer, ... European Journal of Internal Medicine 21 (6), 536-541, 2010 | 46 | 2010 |
| Access to endovascular treatment in remote areas: analysis of the Reperfusion Treatment Registry of Catalonia N Pérez de la Ossa, S Abilleira, L Dorado, X Urra, M Ribó, P Cardona, ... Stroke 47 (5), 1381-1384, 2016 | 41 | 2016 |
| The cytotoxicity of epsilon toxin from Clostridium perfringens on lymphocytes is mediated by MAL protein expression M Blanch, J Dorca-Arévalo, A Not, M Cases, IG de Aranda, ... Molecular and Cellular Biology, 2018 | 34 | 2018 |
| CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS A Martinez-Yelamos, A Rovira, R Sanchez-Valle, S Martinez-Yelamos, ... Journal of neurology 251 (10), 1278, 2004 | 33 | 2004 |
| An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain V Casado, L Romero, L Gubieras, L Alonso, E Moral, S Martinez-Yelamos, ... Multiple Sclerosis Journal 13 (6), 800-804, 2007 | 32 | 2007 |
| The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades L Romero-Pinel, L Bau, E Matas, I León, A Muñoz-Vendrell, P Arroyo, ... Multiple Sclerosis and Related Disorders 68, 104103, 2022 | 28 | 2022 |
| Clinical benefits of interferon beta‐1a in relapsing–remitting MS: a phase IV study O Fernandez, T Arbizu, G Izquierdo, A Martínez‐Yélamos, JM Gata, ... Acta Neurologica Scandinavica 107 (1), 7-11, 2003 | 28 | 2003 |
| Feasibility and effects of structured physical exercise interventions in adults with relapsing-remitting multiple sclerosis: a pilot study E Guillamó, Á Cobo-Calvo, GR Oviedo, N Travier, J Álamo, ... Journal of sports science & medicine 17 (3), 426, 2018 | 16 | 2018 |
| Interferon-β1b in Multiple Sclerosis: Effect on Progression of Disability and Clinical Markers of Treatment Response O Carmona, V Casado, E Moral, L Alonso-Magdalena, ... European Neurology 60 (6), 279-284, 2008 | 13 | 2008 |
| The costs of a multiple sclerosis relapse in Catalonia (Spain) V Casado, S Martinez-Yelamos, A Martinez-Yelamos, O Carmona, ... Neurologia (Barcelona, Spain) 21 (7), 341-347, 2006 | 13 | 2006 |
| Escalas de deterioro, discapacidad y minusvalía en la esclerosis múltiple T Arbizu Urdiain, A Martínez Yélamos, V Casado Ruiz Rev. neurol.(Ed. impr.), 1081-1093, 2002 | 11 | 2002 |
| Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study S Abilleira, A Ribera, A Dávalos, M Ribó, A Chamorro, P Cardona, ... Cerebrovascular Diseases 38 (5), 328-336, 2014 | 7 | 2014 |
| Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis P Naval-Baudin, A Pons-Escoda, À Camins, P Arroyo, M Viveros, ... European Radiology, 1-9, 2023 | 6 | 2023 |
| ¿ Cuánto cuesta un brote de esclerosis múltiple en Cataluña? V Casado, S Martínez-Yelamos, A Martínez-Yélamos, L Romero, E Moral, ... Neurologia 21 (7), 341-347, 2006 | 6 | 2006 |
